Hemsleya amabilis
Hemsleya amabilis · Accepted scientific name
Scientific literature: Very Sparse (2 studies) · ★☆☆☆☆
Hemsleya amabilis is a botanical species that has garnered significant scientific interest due to its potential therapeutic properties. Research focusing on the plant's rhizomes has identified the presence of specific bioactive compounds, most notably Cucurbitacin IIb. When prepared as a concentrated extract, this plant demonstrates notable cytotoxic activity against various malignant lineages. Specifically, studies have highlighted its anticancer potential through targeted interactions with Jurkat cells. These findings suggest that Hemsleya amabilis holds promise as a source for developing new cancer treatment strategies.
- Synonyms
- Not available
- Common names
- Not available
- Family
- Cucurbitaceae
- Distribution
- Not available
- Plant Parts
- Rhizome
Classification
Common Names
Hemsleya amabilis is a unique botanical specimen often recognized by its distinctive local identity. In certain regions, this plant is affectionately known by the common name luo guo di. This specific nomenclature reflects the deep cultural and linguistic connections shared between the plant and its local environment. Understanding these naming traditions provides valuable insight into how different communities interact with their natural surroundings. Such relationships highlight the rich tapestry of biodiversity and human heritage intertwined in the plant kingdom.
Sources: Catalogue of Life (COL)
Taxonomy
Hemsleya amabilis is a distinctive member of the kingdom Plantae that showcases the intricate diversity of the natural world. This species is classified under the class Equisetopsida and belongs to the specific genus Hemsleya. Within this genus, it is further categorized under the order Cucurbitales. Ultimately, it finds its place within the family Cucurbitaceae, connecting it to a broader group of related plants.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Cucurbitales |
| Family | Cucurbitaceae |
| Genus | Hemsleya |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Hemsleya amabilis is a distinctive botanical species primarily found within the Asia-temperate regions. Its natural habitat is most concentrated throughout the diverse landscapes of China. Specifically, the plant thrives in the unique environmental conditions of China South-Central. This localized distribution highlights the importance of protecting its specific ecological niche. Understanding these geographic patterns is essential for the ongoing study of its natural environment.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Biological Activities
Hemsleya amabilis has demonstrated significant therapeutic potential through its documented anticancer and cytotoxic properties. Research indicates that extracts from this medicinal herb can effectively inhibit tumor cell growth and colony formation across various cancer cell lines, including breast and astrocytoma cells. Furthermore, the plant has been shown to promote programmed cell death by inducing apoptosis in these malignant cells. Studies focusing on the plant's rhizomes have also identified specific cucurbitane triterpenoids that possess potent cytotoxic activity. Notably, the main ingredient, Hemslecin A, exhibits remarkable efficacy against human cancer cells, highlighting the plant's importance in pharmacological studies.
Compounds
Hemsleya amabilis is a medicinal plant within the Cucurbitaceae family that serves as a source of the triterpenoid compound Cucurbitacin IIb. Historically used in traditional Chinese medicine to treat intestinal inflammation and dysentery, this specific compound has recently demonstrated significant therapeutic potential in liver health. Research indicates that Cucurbitacin IIb can mitigate acute liver injury by effectively reducing hepatocyte apoptosis and oxidative stress. This protective effect is primarily achieved through the suppression of M1 macrophage polarization via the MAPK and NF-κB signaling pathways. Ultimately, these findings highlight the importance of Hemsleya amabilis as a vital source for developing new treatments for acute liver damage.
Conditions
Hemsleya amabilis exhibits significant medicinal potential through its ability to treat various human cancer cell lines. Research indicates that compounds derived from this plant effectively treat the HCT-8 human cancer cell lines. Additionally, the plant shows therapeutic efficacy in its capacity to treat HeLa cells. These bioactive triterpenoids specifically target the HeLa human cancer cell lines to demonstrate cytotoxic activity. Ultimately, the plant's chemical constituents serve as effective agents to treat Hela and HCT-8 cells.
Preparations
Hemsleya amabilis is prepared as rhizomes to yield bioactive cucurbitane-type triterpene saponins and triterpenoids. These specific rhizome components have demonstrated significant cytotoxic activity against various human cancer cell lines, including HeLa and HCT-8. Additionally, Hemsleya amabilis is prepared as Hemsleya amabilis extract for use in medicinal applications. This extract has been shown to inhibit tumor cell growth and promote apoptosis in several cancer cell types, such as astrocytoma and breast cancer cells. Through these different preparations, the plant serves as a significant source of anticancer agents.
Parts used
Hemsleya amabilis is a medicinal plant within the Cucurbitaceae family that contains valuable chemical constituents in its rhizome. Researchers have successfully isolated several novel cucurbitane-type triterpene saponins, such as xuedanosides K-M, from this specific plant part. Additionally, studies have identified various triterpenoids, including the prominent main ingredient known as Hemslecin A, through advanced spectroscopic analysis. These isolated compounds have demonstrated significant cytotoxic activity against human cancer cell lines like HeLa and HCT-8. Such findings highlight the therapeutic potential of the bioactive molecules found within the rhizomes of this species.